Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|April 15, 2003
Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemiaMaria H Gilleece, Francesco Dazzi
Hematology (Amsterdam, Netherlands)|July 12, 2008
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation studyMaria H Gilleece, Rachel Pearce, David C Linch, et al.
Blood Cancer Journal|May 13, 2021
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMTMaria H Gilleece, Avichai Shimoni, Myriam Labopin, et al.
Nature Medicine|September 15, 2020
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation studyAdrian J C Bloor, Amit Patel, James E Griffin, et al.
American Journal of Hematology|July 8, 2018
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow TransplantationMaria H Gilleece, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Leukemia|August 1, 2019
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMTMaria H Gilleece, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation|July 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMTArnon Nagler, Frédéric Baron, Myriam Labopin, et al.
Blood Advances|August 26, 2018
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP studySalyka Sengsayadeth, Katie S Gatwood, Ariane Boumendil, et al.
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Pageof 1